Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
Poult Sci ; 100(8): 101224, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34157560

RESUMEN

An experiment was conducted to determine the effects of two sources of copper (Cu) from copper sulfate (CuSO4) and dicopper oxide (Cu2O, CoRouge) at three levels of inclusion (15, 75, and 150 mg/kg) on growth performance and gut microbiota of broilers. A total of 840 one-d-old male chickens (Ross 308) were weighed and randomly allocated to seven dietary treatments: negative control (NC, a basal diet without Cu addition), and the NC supplemented with 15, 75, or 150 mg Cu/kg from CuSO4 or Cu2O (12 replicate pens/treatment, 10 chicks per pen). Broilers were challenged by reusing an old litter with high concentrations in Clostridium perfringens to promote necrotic enteritis. Broiler performance was registered at d 21, 35, and 42. Excreta samples were collected at d 14, 28, and 42 for antimicrobial resistance (AMR) analyses. At d 43, one broiler per pen was euthanized to obtain ileal content for microbial characterization. Body weight d 35 and daily gain d 42 improved (P < 0.05) in Cu2O as Cu dose inclusion increased from 15 mg/kg to 150 mg/kg. Supplementation of 150 mg/kg of Cu from Cu2O decreased the abundance (P < 0.01) of some families such as Streptococcaceae and Corynebacteriaceae and increased the abundance (P < 0.05) of some commensal bacteria like Clostridiaceae and Peptostreptococcaceae. Phenotypic AMR was not different among treatments on d 14 and 28. Isolated Enterococcus spp. from broilers fed the NC diet on d 42 showed higher (P < 0.05) resistance to enrofloxacin, gentamicin, and chloramphenicol compared with Cu treatments. By contrast, the isolated Escherichia coli from broilers fed 150 mg/kg of Cu, either from CuSO4 or Cu2O, showed higher (P < 0.05) resistance to streptomycin and chloramphenicol compared to the NC. This study suggests that supplementing 150 mg/kg of Cu from Cu2O establishes changes in the gut microbiota by regulating the bacterial population in the ileum, which may explain the positive impact on broilers' growth performance.


Asunto(s)
Sulfato de Cobre , Microbioma Gastrointestinal , Alimentación Animal/análisis , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Pollos , Cobre/farmacología , Dieta/veterinaria , Suplementos Dietéticos/análisis , Masculino , Óxidos
2.
Sci Rep ; 11(1): 6315, 2021 03 18.
Artículo en Inglés | MEDLINE | ID: mdl-33737699

RESUMEN

There is a high interest on gut health in poultry with special focus on consequences of the intestinal diseases, such as coccidiosis and C. perfringens-induced necrotic enteritis (NE). We developed a custom gene expression panel, which could provide a snapshot of gene expression variation under challenging conditions. Ileum gene expression studies were performed through high throughput reverse transcription quantitative real-time polymerase chain reaction. A deep review on the bibliography was done and genes related to intestinal health were selected for barrier function, immune response, oxidation, digestive hormones, nutrient transport, and metabolism. The panel was firstly tested by using a nutritional/Clostridium perfringens model of intestinal barrier failure (induced using commercial reused litter and wheat-based diets without exogenous supplementation of enzymes) and the consistency of results was evaluated by another experiment under a coccidiosis challenge (orally gavaged with a commercial coccidiosis vaccine, 90× vaccine dose). Growth traits and intestinal morphological analysis were performed to check the gut barrier failure occurrence. Results of ileum gene expression showed a higher expression in genes involved in barrier function and nutrient transport in chickens raised in healthy conditions, while genes involved in immune response presented higher expression in C.perfringens-challenged birds. On the other hand, the Eimeria challenge also altered the expression of genes related to barrier function and metabolism, and increased the expression of genes related to immune response and oxidative stress. The panel developed in the current study gives us an overview of genes and pathways involved in broiler response to pathogen challenge. It also allows us to deep into the study of differences in gene expression pattern and magnitude of responses under either a coccidial vaccine or a NE.


Asunto(s)
Pollos/microbiología , Infecciones por Clostridium/microbiología , Enteritis/microbiología , Enfermedades de las Aves de Corral/microbiología , Alimentación Animal/microbiología , Animales , Infecciones por Clostridium/genética , Clostridium perfringens/efectos de los fármacos , Clostridium perfringens/patogenicidad , Coccidiosis/genética , Coccidiosis/microbiología , Coccidiosis/prevención & control , Suplementos Dietéticos , Eimeria/efectos de los fármacos , Eimeria/patogenicidad , Enteritis/genética , Enteritis/prevención & control , Expresión Génica/efectos de los fármacos , Humanos , Enfermedades de las Aves de Corral/genética , Enfermedades de las Aves de Corral/prevención & control , Vacunas/farmacología
3.
Dig Liver Dis ; 52(6): 658-667, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32362489

RESUMEN

BACKGROUND: The effect of treatment delay on survival in pancreatic ductal adenocarcinoma (PDAC) remains unclear. AIMS: This study aimed to assess the prognostic impact of time to diagnosis and chemotherapy in advanced PDAC and factors influencing the time intervals. METHODS: advanced PDAC patients receiving chemotherapy in five centers in the decade 2007-2016 were included. Key time points during care pathway from clinical presentation to beginning of chemotherapy were retrospectively collected. Multivariate Cox proportional hazard model was performed. RESULTS: A total of 409 patients were included (mean age 66.1 ± 10.3 years; 250 metastatic (61%); 139 received FOLFIRINOX chemotherapy (34%). The median overall survival (OS) was 7.2 months. The median times from first symptoms and from first specialist visit to the beginning of chemotherapy were respectively 100 days and 47 days. None of time intervals was significantly associated with OS. Significant prognostic factors were FOLFIRINOX chemotherapy (HR 0.6 [0.5-0.8]; P < 0.001), metastasis (HR 1.6 [1.3-2.0]; P = 0.001), WHO PS ≥ 2 (HR 1.6 [1.2-2.1]; P < 0.001) and acute pancreatitis as first symptom (HR 2.9 [1.7-4.9]; P < 0.001). Jaundice shortened time to diagnosis (P < 0.001). Acute pancreatitis (P < 0.001) and diabetes (P = 0.01) increased time to treatment. CONCLUSION: Wait times from clinical presentation to beginning of chemotherapy do not influence survival in advanced PDAC.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/mortalidad , Neoplasias Pancreáticas/tratamiento farmacológico , Neoplasias Pancreáticas/mortalidad , Tiempo de Tratamiento , Adenocarcinoma/patología , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Diabetes Mellitus/fisiopatología , Femenino , Fluorouracilo/uso terapéutico , Francia/epidemiología , Humanos , Irinotecán/uso terapéutico , Leucovorina/uso terapéutico , Masculino , Persona de Mediana Edad , Análisis Multivariante , Oxaliplatino/uso terapéutico , Neoplasias Pancreáticas/patología , Pancreatitis/fisiopatología , Pronóstico , Modelos de Riesgos Proporcionales , Estudios Retrospectivos
4.
Poult Sci ; 99(5): 2633-2644, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32359599

RESUMEN

This experiment studied the effect of broiler breeder nutritional strategies on uniformity, carcass traits, tibia parameters, and behavior during rearing and prebreeder periods (up to 22 wk of age). One-day-old pullets (n = 384) were randomly assigned to 4 treatments arranged as a 2 × 2 factorial, with 2 fiber levels (control vs. fibrous diet, 15% diluted in AMEn and nutrient content) and 2 vitamin C feed inclusions (0 vs. 200 mg/kg). At 6, 15, and 22 wk, blood sampling was carried out (4 birds/replicate) to determine serum alkaline phosphatase (ALP) levels, and behavior was observed by visual scan sampling. At 22 wk, carcass traits, tibia parameters, and intestinal morphology were assessed (2 birds/replicate), and tail- and wing-feather integrity of all birds were scored. Fibrous diet did not modify BW uniformity, mortality, or tibia growth when compared with control diet. Pullets fed the fibrous diet had lower tibia breaking strength, elastic modulus, and ash content values (P < 0.05). They also had lower ALP serum level at 6 and 22 wk (P < 0.05), their breast muscle was less developed (18.5 vs. 19.8%, P < 0.05), and their abdominal fat deposition was higher (1.14 vs. 0.87%, P < 0.05). At 15 and 22 wk, they performed, on average, 97% less grasping feather pecking and 45% less non-food object pecking behaviors, and their wing-feather score was lower (P < 0.05) at 22 wk. Tail- and wing-feather scores of the control treatments were reduced by vitamin C inclusion (tail: 0.30 vs. 1.15, P < 0.05; wing: 0.98 vs. 1.26, P < 0.05) at 22 wk. In conclusion, fibrous diet improves carcass traits (reduces breast muscle and increases abdominal fat deposition), deteriorates bone mineral deposition and thus skeletal strength, and reduces stereotypic behaviors, improving wing-feather integrity. Vitamin C inclusion improves tail- and wing-feather integrity of lower in feed allowance.


Asunto(s)
Ácido Ascórbico/metabolismo , Peso Corporal , Pollos/fisiología , Fibras de la Dieta/metabolismo , Longevidad , Conducta Estereotipada , Tibia/química , Alimentación Animal/análisis , Animales , Ácido Ascórbico/administración & dosificación , Peso Corporal/efectos de los fármacos , Dieta/veterinaria , Fibras de la Dieta/administración & dosificación , Suplementos Dietéticos/análisis , Femenino , Longevidad/efectos de los fármacos , Distribución Aleatoria , Reproducción , Conducta Estereotipada/efectos de los fármacos , Tibia/efectos de los fármacos
6.
Aliment Pharmacol Ther ; 26(9): 1209-16, 2007 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-17944735

RESUMEN

BACKGROUND: A prevalence of 1.2% of coeliac disease (CD) in patients with chronic hepatitis C was recently reported, suggesting a possible epidemiological link between these two diseases. However, other studies have not found this relationship. AIM: To conduct a French multicentre prospective study to assess the prevalence of CD in hepatitis C virus (HCV)-infected patients. METHODS: Between June 2003 and November 2005, 624 consecutive HCV-positive out-patients were tested for antiendomysial IgA antibodies (AEA), antigliadin IgA and IgG antibodies (AGA). Patients with positive AEA or IgA AGA and positive IgG AGA in a context of a high suspicion of CD were asked to undergo gastroscopy with duodenal biopsies. RESULTS: Isolated IgA AEA, IgA AGA and IgG AGA were 0.16%, 5.7% and 4.4%, respectively. Gastroscopy was required for 39 patients, 31 were performed (eight refusals), but only 25 duodenal biopsies were performed as six patients had cirrhosis. CD was never detected. CONCLUSIONS: The prevalence of CD in HCV-positive patients was 0% (95% confidence interval: 0-0.59%), but there is a low prevalence of CD in the whole French population.


Asunto(s)
Anticuerpos/sangre , Enfermedad Celíaca/etiología , Gliadina/sangre , Hepatitis C/complicaciones , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Adulto , Anciano , Enfermedad Celíaca/epidemiología , Femenino , Francia , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Prospectivos , Virosis/complicaciones , Virosis/tratamiento farmacológico
7.
Diabetes Metab ; 27(3): 357-64, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11431601

RESUMEN

OBJECTIVE: To clarify the impact of type 2 diabetes mellitus on the gastric emptying rate. MATERIAL AND METHODS: Using a double-isotope scintigraphic technique, we assessed the gastric emptying of a standard liquid-solid meal in 13 obese type 2 diabetic patients without autonomic neuropathy (age: 47.4 +/- 8.6 yr, body mass index: 33.9 +/- 4.8 kg/m(2), glycaemia: 9.1 +/- 2.6 mmol/l) and in 7 controls with similar sex ratio, age, BMI and body fat distribution. RESULTS: The half gastric emptying time for the liquid phase was not significantly different between diabetic patients and controls (respectively: 52.7 +/- 14.5 min and 63.1 +/- 15.2 min). However, the half gastric emptying time for the solid phase was significantly shortened in diabetic patients versus controls (respectively 88.8 +/- 23.2 min in diabetic patients and 113.6 +/- 26.9 min in controls; p<0.04). Furthermore, a negative relationship was highlighted between the half gastric emptying time for the solid phase and basal glycaemia (r=-0.65, p<0.02) in diabetic patients. No significant relationship was found between gastric emptying parameters and cardiac autonomic nerve function, insulin or gastrin levels. CONCLUSION: Solid gastric emptying is accelerated in obese type 2 diabetic patients without patent autonomic neuropathy when compared to obese non diabetic patients.


Asunto(s)
Diabetes Mellitus Tipo 2/fisiopatología , Diabetes Mellitus/fisiopatología , Vaciamiento Gástrico/fisiología , Obesidad , Adulto , Glucemia/análisis , Glucemia/metabolismo , Índice de Masa Corporal , Diabetes Mellitus/sangre , Diabetes Mellitus Tipo 2/sangre , Neuropatías Diabéticas , Femenino , Hemoglobina Glucada/análisis , Humanos , Radioisótopos de Indio , Masculino , Persona de Mediana Edad , Selección de Paciente , Ácido Pentético , Radiofármacos , Valores de Referencia , Agregado de Albúmina Marcado con Tecnecio Tc 99m
13.
Gastroenterol Clin Biol ; 20(5): 502-5, 1996.
Artículo en Francés | MEDLINE | ID: mdl-8761149

RESUMEN

In patients successfully treated for hereditary retinoblastoma, the risk of developing a second non-ocular tumor has been reported. We report the first case of primary hepatic leiomyosarcoma in a 39 year-old woman who has been treated 37 years before for hereditary retinoblastoma of the left eye. The patient presented with right upper quadrant abdominal pain and fever. Histological diagnosis was made by liver biopsy. As surgical resection was impossible, chemotherapy with epirubicin, then ifosfamide, etoposide and cisplatin was performed. The patient died 22 months after diagnosis. Genetic abnormalities observed in hereditary retinoblastoma, which probably resulted in a predisposition to the development of hepatic cancer in this patient, were not investigated.


Asunto(s)
Neoplasias del Ojo/genética , Leiomioma Epitelioide , Neoplasias Hepáticas , Neoplasias Primarias Secundarias , Retinoblastoma/genética , Adulto , Neoplasias del Ojo/cirugía , Femenino , Humanos , Leiomioma Epitelioide/terapia , Neoplasias Hepáticas/terapia , Neoplasias Primarias Secundarias/terapia , Retinoblastoma/cirugía , Factores de Tiempo
14.
Gastroenterol Clin Biol ; 19(5): 537-41, 1995 May.
Artículo en Francés | MEDLINE | ID: mdl-7590008

RESUMEN

We report a case of regressive peliosis hepatis, which occurred in a 55 year-old woman with diffuse intestinal lymphomatous polyposis in remission after treatment with chemotherapy and radiotherapy, and which was cleared after one month treatment with erythromycin. The Warthin-Sarry stain, performed to identify a specific agent such as Rochalimaea quintana and henselae, was negative, and the polymerase chain reaction technique could not be performed. Regressive cases of peliosis hepatis are rare, and 4 out of 7 have been reported after antibiotic treatment. Two of them were observed after an antibiotic regimen with erythromycin in patients with HIV disease, and the bacilli Rochalimaea quintana and henselae were identified in liver tissue with Warthin-Starry stain and polymerase chain reaction technique. The observation and the regressive cases recently reported elsewhere, suggest that appropriate antibiotic treatment should be proposed when peliosis hepatis occurs.


Asunto(s)
Eritromicina/uso terapéutico , Neoplasias Intestinales/complicaciones , Linfoma no Hodgkin/complicaciones , Peliosis Hepática/etiología , Antibacterianos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Terapia Combinada , Femenino , Humanos , Neoplasias Intestinales/tratamiento farmacológico , Neoplasias Intestinales/radioterapia , Linfoma no Hodgkin/tratamiento farmacológico , Linfoma no Hodgkin/radioterapia , Persona de Mediana Edad , Peliosis Hepática/tratamiento farmacológico , Peliosis Hepática/patología , Inducción de Remisión
15.
Rev Prat ; 44(20): 2688-93, 1994 Dec 15.
Artículo en Francés | MEDLINE | ID: mdl-7878357

RESUMEN

Precursors of colorectal carcinoma are adenomatous polyps, sporadic or arising in familial adenomatous polyposis and Lynch syndrome and chronic inflammatory lesions related to ulcerative colitis and Crohn's disease. The adenoma-carcinoma sequence is well established and early detection and removal of colorectal adenomas is thought to prevent colorectal cancer in high risk asymptomatic persons, i.e. subjects over 45 years, with personal or familial history of adenomas and colorectal cancers. The precancerous potential of adenomatous polyps varies according to tissue type, with increased risk with the extent of the villous component, high grade of dysplasia, large size greater than 1 cm and multiple adenomas. The development of de novo colorectal cancer from normal mucosa with flat adenomas has been recently emphasized. The risk of colonic cancer in patients with ulcerative colitis and Crohn's disease is controversed.


Asunto(s)
Neoplasias Colorrectales/epidemiología , Lesiones Precancerosas/patología , Anciano , Enfermedades del Colon/patología , Neoplasias Colorrectales/patología , Humanos , Persona de Mediana Edad , Enfermedades del Recto/patología , Factores de Riesgo
16.
Gastroenterol Clin Biol ; 18(6-7): 652-6, 1994.
Artículo en Francés | MEDLINE | ID: mdl-7875424

RESUMEN

Subcutaneous seeding after percutaneous ultrasonically guided fine needle aspiration of liver tumours is a rare complication and only a few cases have been reported. We report a new case of cutaneous implantation following a fine needle (21.5 gauge of external diameter) aspiration biopsy of a superficial colonic liver metastasis, as shown by a subcutaneous nodule and increased serum carcinoembryonnary-antigen. We discuss the risk factors of this rare complication, especially the thickness of the liver parenchyma along the needle tract and precautions which can be taken for prevention.


Asunto(s)
Adenocarcinoma/patología , Biopsia con Aguja/efectos adversos , Neoplasias del Colon/patología , Neoplasias Hepáticas/etiología , Siembra Neoplásica , Resultado Fatal , Femenino , Humanos , Neoplasias Hepáticas/diagnóstico por imagen , Neoplasias Hepáticas/secundario , Persona de Mediana Edad , Complicaciones Posoperatorias , Tomografía Computarizada por Rayos X , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...